Scientists in the UK have developed a new technique called "mito-priming" that gets cancer cells addicted to drugs that kill them within minutes. Mito-priming works by producing equal amounts of toxic and protective proteins in cells, leaving them highly sensitive to drugs that inhibit the protective proteins. This allows rapid screening of potential anti-cancer drugs and improves ways to kill cancer cells.